Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
58M
-
Shares change
-
+4.39M
-
Total reported value, excl. options
-
$524M
-
Value change
-
+$37.8M
-
Put/Call ratio
-
0.84
-
Number of buys
-
56
-
Number of sells
-
-40
-
Price
-
$9.03
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q1 2015
117 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q1 2015.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58M shares
of 210M outstanding shares and own 27.68% of the company stock.
Largest 10 shareholders include FMR LLC (10.8M shares), BAKER BROS. ADVISORS LP (10.5M shares), WELLINGTON MANAGEMENT GROUP LLP (7.02M shares), STATE STREET CORP (3.34M shares), BlackRock Fund Advisors (2.86M shares), VANGUARD GROUP INC (2.46M shares), MILLENNIUM MANAGEMENT LLC (2.43M shares), RTW INVESTMENTS, LLC (2.26M shares), BlackRock Institutional Trust Company, N.A. (1.91M shares), and VHCP Management, LLC (1.74M shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.